ArticleFrontiers in immunology2024

Prevalence of anti-lymphocyte IgM autoantibodies driving complement activation in COVID-19 patients.

Ainhoa Pérez-Díez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.